MedTrace Logo

Comparison of Screening Tools for Coronary Artery Disease

NCT00383955 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2006-10-04

No results posted yet for this study

Summary

Coronary artery disease (CAD) is a silent killer that may go undetected for years. It is the leading cause of death with no limitation to geographic boundaries accounting to about 16.7 million deaths world wide. Different studies have shown that South Asians populations are more prone to CAD where it is emerging as an epidemic. According to a study conducted in Karachi it is estimated that the overall prevalence of cardiovascular diseases in Pakistan is 26.9% with 23.7% in men and 30.0% in women. However tools for measuring CAD have not being adequately validated. This study is designed to develop screening tools and to determine test characteristics of Rose Questionnaire and Minnesota Coded ECG alone and in combination for diagnosis of CAD, using MPI as gold standard in Pakistan.

Conditions

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Dr. Tazeen H Jafar, MD, MPH · Aga Khan University

  • Dr. Shazia S Abbas · Aga Khan University

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00383955 on ClinicalTrials.gov